Medtronic’s Ishrak sees Chinese health reform as boon
14-Apr-17, Mass Device
Healthcare reform in China could be a major boon to Medtronic, according to CEO Omar Ishrak. Ishrak spoke to the China Daily about how such reforms could allow Medtronic to expand care in the region and lower costs.
%20Medtronic.jpg "Medtronics Ishrak sees Chinese health reform as boon to the medical device business (c) Medtronic")
Image: Medtronic
Ishrak touted that Medtronic would be the first company to open a bio-prosthetic heart valve manufacturing site in Shanghai, saying that the facility would help relieve the shortage of such valves in China and globally.
“In 10 years, probably, the Chinese market would have outpaced the US market... Chinese government has a systematic approach to resolve the huge demand for better healthcare service through managing the pace of investment and by improving training of medical professionals."